USING SINGLE CELL TRANSCRIPTOMICS TO UNDERSTAND TUMOR AND IMMUNE HETEROGENEITY DRIVING RESISTANCE AND TO RATIONALLY SELECT IMMUNE THERAPY IN ADVANCED

Georgetown University, Washington DC

Investigators